Form D · Biotechnology
River Vision Development Corp.
New York, NY · CIK 0001564262
Offering snapshot reported Jan 21, 2016 · SEC filing
- Reported sold
- $5M Offering amount: $5M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $250K Reported outside-investor minimum
- First sale
- Jan 20, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 21, 2016 | Initial | $5,000,000 | No comparison | 3 | SEC filing |
| Feb 2, 2015 | Initial | $5,300,000 | No comparison | 2 | SEC filing |
| Jan 7, 2014 | Initial | $6,000,000 | No comparison | 2 | SEC filing |
| Dec 10, 2012 | Initial | $16,800,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-255664
Source: Form D, filed Jan 21, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian Gallagher | Director |
| Johan Kordel | Director |
| Dave Madden | Director, Executive |
| David M Madden | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
One Rockefeller Plaza Suite 1204
New York, NY, 10020
New York, NY, 10020